Furthermore, CLEC2D was frequently expressed in breast cancer with neoadjuvant chemotherapy, and its expression was upregulated by EPI in MDA-MB-231 and T-47D cells, and by DTX in MCF-7 and MDA-MB-231 cells. This evidence concerns the gene CLEC2D and breast cancer.